DPW
IRWD icon

DiNuzzo Private Wealth’s Ironwood Pharmaceuticals IRWD Stock Holding History

DiNuzzo Private Wealth’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15
Closed -$98 – 1451
2024
Q2 		$98 Sell
15
-3
-17% -$21 ﹤0.01% 1346
2024
Q1 		$157 Buy
18
+1
+6% +$12 ﹤0.01% 1237
2023
Q4 		$195 Buy
+17
New +$168 ﹤0.01% 1229

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DiNuzzo Private Wealth's IRWD Position: Q3 2024 in Review

DiNuzzo Private Wealth sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 15 shares — an estimated $98 sold.

DiNuzzo Private Wealth first reported a position in IRWD in Q4 2023 and held it in 3 quarters. The position peaked at $195 in Q4 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • DiNuzzo Private Wealth reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 15 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $98.
  • DiNuzzo Private Wealth first reported a position in Ironwood Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • DiNuzzo Private Wealth's Ironwood Pharmaceuticals position peaked at $195 in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2024, filed 17 Oct 2024.